AI Solutions designed for clinical trials
TrialKey is an AI Agent automating processes for CROs with AI to improve efficiency and enhance result accuracy.
TrialKey is a powerful tool for optimising clinical trial designs using advanced AI and machine learning. Built on data from over 520,000 trials, simulates trial scenarios over 100,000 times to provide data-driven recommendations for critical trial elements through robust biostatistical validation. With over 92% accuracy in predicting trial phase completion, TrialKey helps researchers navigate the complexities of trial design more effectively.
The Clinical Trial Design Report offers a strategic overview, while the others dive into specific aspects with detailed analysis and supporting literature. Together, these reports provide a comprehensive toolkit to design, optimise, and execute clinical trials with precision.
Request a Sample Report
Preliminary Report
Our free report equips CROs with actionable insights to strengthen proposals, refine strategies, and attract sponsors. Backed by 30+ years of global trial data, you’ll gain the tools needed to outpace competitors and win critical projects. Disclaimer: Preliminary Reports are available only for pharmaceutical and contract research organisations. The content is not available to funds or other entities.
Clinical Trial Design Report
Offers a strategic overview of your trial’s design. This report identifies critical variables like patient recruitment, inclusion/exclusion criteria, and endpoint selection. By combining actionable insights with competitor benchmarking, it provides optimal ranges and recommendations to refine your trial strategy effectively.
Body of Research Report
Provides an in-depth analysis of existing scientific literature and historical data in your therapeutic area. This report identifies trends, gaps, and opportunities, giving researchers a comprehensive understanding to strengthen their trial design and scientific rationale.
Real World Evidence Report
This report validates trial designs by analysing how your intervention performs in real-world settings, offering insights into patient behaviours and treatment effectiveness beyond the clinical environment.
Competitor Analysis and
Prediction Report
An in-depth evaluation of competitor trials, including their design, strategies, and outcomes. Leveraging advanced analytics, it simulates the probability of success for the closest competitor trials, offering a detailed distribution and key insights into their likelihood of achieving success. This report also includes timelines for trial duration and completion, helping sponsors identify strategic opportunities to optimise their trial planning. Additionally, the report evaluates the technologies used in competitor trials. It highlights the most effective technologies, based on historical success rates and current trends, enabling sponsors to identify the technologies most likely to succeed in their therapeutic area. With this comprehensive analysis, sponsors can better position their trial for differentiation and success in a competitive landscape.
Site Selection Report
Recommends trial sites based on performance in similar trials and specific expertise in your condition. The report evaluates key factors such as trial success history. By leveraging data from prior site performance, it ensures you select locations capable of delivering trial success.
Biotech Investor Insights Report
Empowers biotech investors with optimised decision-making tools, using predictive analytics to identify promising biotech and pharmaceutical stocks by forecasting clinical trial success rates. It enhances due diligence by reducing uncertainty through detailed trial assessments, improving portfolio quality. Offering unparalleled market intelligence, the report highlights emerging trends and strategic investment opportunities. With exclusive proprietary data and the ability to pinpoint over 200 market inflection points annually across US and Australian markets, TrialKey delivers a competitive edge, ensuring informed, data-driven investment strategies that drive superior portfolio performance.
Integration of Reports
The Clinical Trial Design Report offers a strategic overview, while the others dive into specific aspects with detailed analysis and supporting literature. Together, these reports provide a comprehensive toolkit to design, optimise, and execute clinical trials with precision.
Compare Our Plans
Our trial management solutions offer three tailored plans to suit different stages of your project: the Essential Plan, Professional Plan, and Enterprise Plan. Compare these plans to find the best fit for your needs.
Trusted By
Request an Expert Consultation
TrialKey is more than a feasibility tool – it’s a competitive advantage.
Our AI-powered biostatistical tools provide tailored insights, helping you validate your research question, determine sample sizes, and optimise study protocols for clarity, feasibility, and reliability.
Join our partners transforming clinical trials with TrialKey.
